Martine A Rothblatt sold $4.7M of UTHR
Chairperson & CEO at UNITED THERAPEUTICS Corp. 9,500 shares at an average of $493.46, traded Sep 2, 2026, filed Sep 3, 2026.
Score components
- +25RoleCEO
- +25Trade size$4.7M at market
- 0Share of holdings soldSold 2.8% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001106578-26-000134, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | MOption exercise Common Stockindirect: by Trust10b5-1 | +9,500 | $135.42 | $1.3M | 333,943 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -120 | $477.70 | $57k | 333,823 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -160 | $478.85 | $77k | 333,663 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -160 | $479.89 | $77k | 333,503 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -80 | $482.61 | $39k | 333,423 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -120 | $485.12 | $58k | 333,303 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -160 | $486.32 | $78k | 333,143 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -240 | $489.06 | $117k | 332,903 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -560 | $490.19 | $275k | 332,343 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -1,833 | $491.38 | $901k | 330,510 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -2,067 | $492.25 | $1.0M | 328,443 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -520 | $493.59 | $257k | 327,923 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -520 | $494.33 | $257k | 327,403 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -423 | $495.95 | $210k | 326,980 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -777 | $496.95 | $386k | 326,203 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -364 | $498.21 | $181k | 325,839 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -542 | $498.97 | $270k | 325,297 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -54 | $500.22 | $27k | 325,243 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -160 | $501.06 | $80k | 325,083 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -120 | $502.01 | $60k | 324,963 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -200 | $504.15 | $101k | 324,763 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -40 | $505.20 | $20k | 324,723 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -40 | $506.27 | $20k | 324,683 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -80 | $508.36 | $41k | 324,603 | 40 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -160 | $510.05 | $82k | 324,443 | 40 d ago |
| Sep 2, 2026 | MOption exercise Stock Optionderivativeindirect: by Trust10b5-1 | -9,500 | $0.00 | $0 | 8,910 | 40 d ago |
Related signals
Other insiders at UNITED THERAPEUTICS Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.2M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.2M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.5M 9,500 shares | -3% | |
| 18Weak | UNITED THERAPEUTICS Corp | Paul A Mahon EVP & GENERAL COUNSEL | $4.7M 8,300 shares | -16% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $3.9M 7,580 shares | -2% | |
| 38Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $1.1M 1,920 shares | -1% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $4.5M 9,500 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.